Lialda Related Clinical Trials
A Study Comparing the Acceptability of Pentasa® Sachets Versus Pentasa® Tablets in Children With Crohn´s Disease [Completed]
Sulfamethoxazole Drug Interaction Study With MMX� Mesalazine/Mesalamine [Recruiting]
Assessing the Safety/Efficacy of Asacol® Given Every 12 Hours to Children and Adolescents for the Maintenance of Remission of Ulcerative Colitis [Recruiting]
Canadian Active & Maintenance Modified Pentasa Study [Recruiting]
Ability to Maintain or Achieve Clinical and Endoscopic Remission With MMX Mesalamine Once Daily in Adults With Ulcerative Colitis [Recruiting]
Curcumin + Aminosalicylic Acid (5ASA) Versus 5ASA Alone in the Treatment of Mild to Moderate Ulcerative Colitis [Recruiting]
The Effect of Long-Acting Mesalamine on Post-Infective Irritable Bowel Syndrome- A Pilot Study [Recruiting]
Study of the Safety and Tolerability of ALTH12 Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis [Recruiting]
Predicting Response to Standardized Pediatric Colitis Therapy [Recruiting]
Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative Colitis [Recruiting]
Once Daily Versus Conventional Dosing of Asacol in the Maintenance of Quiescent Ulcerative Colitis [Terminated]
Cimzia Versus Mesalamine for Crohn's Recurrence [Not yet recruiting]
Clinical Trial With Mesalamine 1g Suppositories [Recruiting]
Mechanistic Randomized Controlled Trial (RCT) of Mesalazine in Symptomatic Diverticular Disease [Recruiting]
Efficacy of Mesalamine in Diarrhea-predominant Irritable Bowel Syndrome (dIBS) [Recruiting]
Once Versus Twice Daily Mesalamine to Induce Remission in Pediatric Ulcerative Colitis [Recruiting]
Mesalazine Treatment in IBS (The MIBS Study) [Recruiting]
Mesalazine 4g Once Daily Versus 4g in Two Divided Doses in Active Ulcerative Colitis. [Recruiting]
The Influence of 5–Aminosalicylates on Thiopurine Metabolite Levels [Completed]
TID 1000 mg Mesalazine Versus TID 2x500 mg Mesalazine in Active Ulcerative Colitis (UC) [Not yet recruiting]
Comparative Efficacy and Safety Study in Patients With Active Ulcerative Colitis [Recruiting]
Comparative Efficacy and Safety Study in Patients With Ulcerative Colitis in Remission Phase [Recruiting]
Targeting Oxidative Stress in Chronic Beryllium Disease [Recruiting]
Efficacy and Safety of Asacolâ„¢ 4.8 g/Day (800 mg Tablets) for the Treatment of Active Ulcerative Colitis [Recruiting]
Mesalazine Therapy in Patients With Irritable Bowel Syndrome [Recruiting]
A Study With Pentasa in Patients With Active Crohn's Disease [Recruiting]
The Colitis Once Daily Asacol Study [Recruiting]
Assessing the Safety/Efficacy of Asacol® Given Every 12 Hours to Children and Adolescents With Active Ulcerative Colitis [Recruiting]
Mesalamine Granules for Irritable Bowel Syndrome (IBS) With Diarrhea [Recruiting]
Casein Glycomacropeptide in Active Distal Ulcerative Colitis (Pilot Study) [Recruiting]
Adherence to Mesalamine Profile for Patients With Inflammatory Bowel Disease [Recruiting]
Asacol Acute Diverticulitis(DIVA)Study [Recruiting]
Conventional Step-Up Versus Infliximab Monotherapy in Patients With Ulcerative Colitis (Study P05553) [Recruiting]
OD vs. TID Dosing With Mesalazine Granules in Active Ulcerative Colitis [Completed]
Two Doses Mesalazine Granules Versus Placebo for the Prevention of Recurrence of Diverticulitis [Recruiting]
Dose Escalation and Remission (DEAR) [Recruiting]
Safety and Compliance of Taking Mesalamine Once a Day in Pediatric Patients [Terminated]
Observational Study in the Management of Ulcerative Colitis With Oral 5-ASA [Not yet recruiting]
The Effect on Mucosal Healing With Pentasa Sachet in Mild to Moderate Active "Drug: Crohn's Disease" [Not yet recruiting]
CORE: A Study of OPC-6535 With Asacol® in Maintaining Ulcerative Colitis (UC) Remission [Completed]
A Study of Asacol Absorption, Metabolism and Excretion in Children and Adolescents With Ulcerative Colitis. [Completed]
Mesalazine for the Treatment of Diarrhoea-predominant Irritable Bowel Syndrome (IBS-D) [Recruiting]
A Double Blind Study for the Treatment of Acute Ulcerative Colitis [Completed]
Efficacy and Safety of SPD476 in Maintaining Remission in Patients With Ulcerative Colitis [Recruiting]
Budesonide Versus Mesalazine Versus Placebo in Lymphocytic Colitis [Recruiting]
Phase II Dose-Ranging Study in Subjects With Mild to Moderate Ulcerative Colitis Treated With SPD476 [Completed]
Qualitative Study of Topical Mesalamine Adherence in Patients With Ulcerative Colitis(UC) [Recruiting]
Pentasa Once Daily in Ulcerative Colitis for Maintenance of Remission [Completed]
Mesalazine Granules vs. Placebo for the Prevention of Recurrence of Diverticulitis [Recruiting]
Asacol Dosing Study for Active Ulcerative Colitis [Completed]
Oral Budesonide vs. Oral Mesalazine in Active Crohn's Disease (CD) [Completed]
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission [Terminated]
Prevention of Recurrence of Diverticulitis [Recruiting]
Balsalazide Disodium vs. Mesalamine in Mildly to Moderately Active Ulcerative Colitis [Completed]
Safety and Efficacy of Two Different Doses of Asacol in the Treatment of Moderately Active Ulcerative Colitis [Completed]
Study of Effects and of Modifications in Apoptosis Regulators Observed After Stopping 5-ASA Treatment in Patients With Inactive Ulcerative Colitis [Recruiting]
Budesonide Capsules vs. Mesalazine Granules vs. Placebo in Collagenous Colitis [Recruiting]
(CB-01-02/01)Randomized Placebo Controlled Trial of Budesonide-MMXâ„¢ (CB-01-02) 6 mg and 9 mg in Patients With Ulcerative Colitis [Recruiting]
A Comparison of Once a Day Dose Compared to 2 Doses/Day [Recruiting]
Mesalamine and Reproductive Health Study [Recruiting]
Prevention of Recurrence of Diverticulitis [Recruiting]
Safety and Efficacy of SPD476 (Mesalazine) Given Twice Daily (2.4 g/Day) vs SPD476 Given as a Single Dose (4.8 g/Day) in Subjects With Acute Mild to Moderate Ulcerative Colitis [Completed]
Strategies in Maintenance for Patients Receiving Long-Term Therapy" (S.I.M.P.L.E.) [Recruiting]
Effect of GSK1399686 in Patients With Mild to Moderately Active Ulcerative Colitis [Recruiting]
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA [Recruiting]
Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis [Recruiting]
Medical Treatment of Colitis in Patients With Hermansky-Pudlak Syndrome [Recruiting]
A Phase II Study to Explore the Safety and Activity of Dersalazine in Patients With Mild to Moderate Ulcerative Colitis [Recruiting]
Safety and Tolerability of SPD476 in Maintaining Remission in Patients With Ulcerative Colitis. [Completed]
Effect of an Anti-Inflammatory Drug on Gut Mucosa in HIV Infected Patients [Completed]
A Dose-finding and Confirmatory Trial of OPC-6535 in Patients With Active Crohn's Disease [Recruiting]
NICE: Nolpitantium Besylate In Patients With Ulcerative Colitis a Double-Blind, Placebo Controlled Efficacy and Safety Study [Completed]
SONIC Study of Biologic and Immunomodulator Naive Patients in Crohn's Disease [Active, not recruiting]
A Dose-Finding Study of OPC-6535 in Patients With Active Crohn's Disease [Terminated]
Fecal Biomarker Study for Patients With Ulcerative Colitis [Recruiting]
Monoclonal Antibody Treatment of Crohn's Disease [Completed]
Crohn's Disease Stem Cell Transplantation [Recruiting]
A Dose-Finding Study of OPC-6535 in Patients With Active Ulcerative Colitis [Terminated]
Methods of Improvement Adherence With Therapy in Ulcerative Colitis. [Not yet recruiting]
New Tablet Formulation and Dosing Regimen of Balsalazide Disodium in Mildly to Moderately Active Ulcerative Colitis [Completed]
Ciprofloxacin for the Prevention of Postoperative Endoscopic Recurrence in Crohn's Disease [Recruiting]
Phase II Study of HMPL-004 in Patients With Ulcerative Colitis [Recruiting]
The Effect of Infliximab on Sperm Quality [Not yet recruiting]
Phase II Pilot Study of Olsalazine for Ankylosing Spondylitis [Completed]
Alicaforsen (ISIS 2302) in Patients With Active Crohn's Disease [Completed]
Alicaforsen (ISIS 2302) in Patients With Active Crohn’s Disease
ISIS 2302-CS22, A 6-Week, Active-Controlled Clinical Study to Evaluate the Effectiveness of Alicaforsen (ISIS 2302) in Patients With Mild to Moderate Active Ulcerative Colitis [Completed]
VSL#3 Treatment in Children With Crohn's Disease [Not yet recruiting]
Randomized Placebo Controlled Trial of Budesonide-MMXâ„¢ 6 mg and 9 mg in Patients With Ulcerative Colitis [Recruiting]
Study To Determine The Pharmacokinetics Of Sulfasalazine In Children With Juvenile Idiopathic Arthritis [Recruiting]
|
